Principal Financial Group’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $75.5M | Buy |
121,053
+628
| +0.5% | +$427K | 0.04% | 389 |
|
|
2026
Q1 | $93M | Buy |
120,425
+800
| +0.7% | +$612K | 0.05% | 302 |
|
|
2025
Q4 | $92.3M | Buy |
119,625
+1,142
| +1% | +$776K | 0.05% | 290 |
|
|
2025
Q3 | $66.6M | Sell |
118,483
-4,766
| -4% | -$2.69M | 0.03% | 374 |
|
|
2025
Q2 | $64.7M | Sell |
123,249
-6,376
| -5% | -$3.56M | 0.03% | 384 |
|
|
2025
Q1 | $82.2M | Sell |
129,625
-865
| -0.7% | -$595K | 0.05% | 316 |
|
|
2024
Q4 | $93M | Sell |
130,490
-42,602
| -25% | -$35.8M | 0.05% | 305 |
|
|
2024
Q3 | $182M | Buy |
173,092
+2,828
| +2% | +$3.15M | 0.1% | 182 |
|
|
2024
Q2 | $179M | Buy |
170,264
+1,852
| +1% | +$1.8M | 0.11% | 172 |
|
|
2024
Q1 | $162M | Buy |
168,412
+37,685
| +29% | +$35.8M | 0.1% | 184 |
|
|
2023
Q4 | $115M | Sell |
130,727
-628
| -0.5% | -$517K | 0.07% | 224 |
|
|
2023
Q3 | $108M | Sell |
131,355
-1,672
| -1% | -$1.31M | 0.08% | 214 |
|
|
2023
Q2 | $95.6M | Sell |
133,027
-3,241
| -2% | -$2.5M | 0.07% | 254 |
|
|
2023
Q1 | $112M | Buy |
136,268
+1,614
| +1% | +$1.22M | 0.08% | 223 |
|
|
2022
Q4 | $97.2M | Sell |
134,654
-9,777
| -7% | -$7.21M | 0.07% | 238 |
|
|
2022
Q3 | $99.5M | Buy |
144,431
+14,963
| +12% | +$9.42M | 0.08% | 218 |
|
|
2022
Q2 | $76.5M | Buy |
129,468
+3,323
| +3% | +$2.16M | 0.06% | 285 |
|
|
2022
Q1 | $88.1M | Buy |
126,145
+264
| +0.2% | +$167K | 0.06% | 283 |
|
|
2021
Q4 | $79.5M | Sell |
125,881
-2,415
| -2% | -$1.48M | 0.05% | 310 |
|
|
2021
Q3 | $77.6M | Buy |
128,296
+2,682
| +2% | +$1.67M | 0.05% | 302 |
|
|
2021
Q2 | $70.2M | Sell |
125,614
-6,296
| -5% | -$3.19M | 0.05% | 340 |
|
|
2021
Q1 | $62.4M | Sell |
131,910
-9,970
| -7% | -$4.85M | 0.04% | 357 |
|
|
2020
Q4 | $68.5M | Sell |
141,880
-6,275
| -4% | -$3.39M | 0.05% | 319 |
|
|
2020
Q3 | $82.9M | Sell |
148,155
-3,617
| -2% | -$2.19M | 0.07% | 265 |
|
|
2020
Q2 | $94.7M | Buy |
151,772
+34,093
| +29% | +$19.4M | 0.08% | 251 |
|
|
2020
Q1 | $57.5M | Buy |
117,679
+6,645
| +6% | +$2.74M | 0.06% | 296 |
|
|
2019
Q4 | $41.7M | Sell |
111,034
-3,453
| -3% | -$1.16M | 0.03% | 439 |
|
|
2019
Q3 | $31.8M | Buy |
114,487
+1,639
| +1% | +$485K | 0.03% | 522 |
|
|
2019
Q2 | $35.3M | Sell |
112,848
-2,952
| -3% | -$983K | 0.03% | 483 |
|
|
2019
Q1 | $47.5M | Buy |
115,800
+712
| +0.6% | +$293K | 0.04% | 398 |
|
|
2018
Q4 | $43M | Sell |
115,088
-1,543
| -1% | -$565K | 0.05% | 394 |
|
|
2018
Q3 | $47.1M | Buy |
116,631
+2,315
| +2% | +$881K | 0.04% | 437 |
|
|
2018
Q2 | $39.4M | Buy |
114,316
+442
| +0.4% | +$138K | 0.04% | 468 |
|
|
2018
Q1 | $39.2M | Sell |
113,874
-295
| -0.3% | -$103K | 0.04% | 468 |
|
|
2017
Q4 | $42.9M | Buy |
114,169
+2,087
| +2% | +$845K | 0.04% | 460 |
|
|
2017
Q3 | $50.1M | Sell |
112,082
-3,119
| -3% | -$1.48M | 0.05% | 414 |
|
|
2017
Q2 | $56.6M | Buy |
115,201
+2,646
| +2% | +$1.16M | 0.06% | 376 |
|
|
2017
Q1 | $43.6M | Buy |
112,555
+2,263
| +2% | +$839K | 0.05% | 371 |
|
|
2016
Q4 | $40.5M | Sell |
110,292
-404
| -0.4% | -$154K | 0.05% | 375 |
|
|
2016
Q3 | $44.5M | Sell |
110,696
-1,275
| -1% | -$511K | 0.06% | 319 |
|
|
2016
Q2 | $39.1M | Buy |
111,971
+2,350
| +2% | +$905K | 0.05% | 323 |
|
|
2016
Q1 | $39.5M | Buy |
109,621
+3,038
| +3% | +$1.25M | 0.06% | 317 |
|
|
2015
Q4 | $57.9M | Buy |
106,583
+2,198
| +2% | +$1.19M | 0.09% | 246 |
|
|
2015
Q3 | $48.6M | Buy |
104,385
+3,236
| +3% | +$1.74M | 0.08% | 273 |
|
|
2015
Q2 | $51.6M | Buy |
101,149
+4,346
| +4% | +$2.12M | 0.08% | 271 |
|
|
2015
Q1 | $43.7M | Buy |
96,803
+2,007
| +2% | +$851K | 0.07% | 301 |
|
|
2014
Q4 | $38.9M | Buy |
94,796
+2,855
| +3% | +$1.12M | 0.06% | 313 |
|
|
2014
Q3 | $33.1M | Sell |
91,941
-6,359
| -6% | -$2.13M | 0.06% | 333 |
|
|
2014
Q2 | $27.8M | Sell |
98,300
-965
| -1% | -$286K | 0.05% | 391 |
|
|
2014
Q1 | $29.8M | Buy |
99,265
+2,189
| +2% | +$674K | 0.05% | 370 |
|
|
2013
Q4 | $26.7M | Buy |
97,076
+758
| +0.8% | +$218K | 0.05% | 394 |
|
|
2013
Q3 | $30.1M | Buy |
96,318
+2,806
| +3% | +$738K | 0.06% | 338 |
|
|
2013
Q2 | $21M | Buy |
+93,512
| New | +$21.8M | 0.05% | 425 |
|
Other funds holding REGN
Principal Financial Group's REGN Position: Q2 2026 in Review
Principal Financial Group increased its Regeneron Pharmaceuticals (REGN) stake by 0.52% in Q2 2026, buying an estimated $427K and bringing the position to 121,053 shares worth $75.5M. The position accounts for 0.04% of the portfolio, ranked #389.
Principal Financial Group first reported a position in REGN in Q2 2013 and has held it in 53 quarters since. The position peaked at $182M in Q3 2024. 1,338 funds tracked by Wall St. Rank hold REGN as of Q2 2026.
- Principal Financial Group held 121,053 shares of Regeneron Pharmaceuticals worth $75.5M as of Q2 2026.
- Principal Financial Group bought 628 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $427K.
- Regeneron Pharmaceuticals made up 0.04% of Principal Financial Group's portfolio in Q2 2026, its #389 holding.
- Principal Financial Group first reported a position in Regeneron Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
- Principal Financial Group's Regeneron Pharmaceuticals position peaked at $182M in Q3 2024.
- 1,338 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.
Based on Principal Financial Group's 13F filing for Q2 2026, filed 4 Aug 2026.